Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Pyxis Oncology, Inc. | 690,131 | reported | 03 Feb 2026 | tx 7+1,035,211 |
| FIVE PRIME THERAPEUTICS INC | 0 | reported | 16 Apr 2021 | tx 5+555,000−560,059 |
| Foundation Medicine, Inc. | 0 | reported | 31 Jul 2018 | tx 2+33,421−33,421 |
| Repare Therapeutics Inc. | 0 | reported | 28 Jan 2026 | tx 6+152,900−7,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2026 | GRANT_AWARD | Pyxis Oncology, Inc. | 690,131 | 0.00 USD | deriv |
| 28 Jan 2026 | OTHER | Repare Therapeutics Inc. | 7,500 | — | |
| 31 Mar 2025 | GRANT_AWARD | Pyxis Oncology, Inc. | 36,979 | 0.98 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Repare Therapeutics Inc. | 27,200 | 0.00 USD | deriv |
| 26 Mar 2024 | GRANT_AWARD | Pyxis Oncology, Inc. | 44,024 | 3.83 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Repare Therapeutics Inc. | 27,200 | 0.00 USD | deriv |
| 24 Mar 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 139,355 | 0.00 USD | |
| 13 May 2022 | GRANT_AWARD | Repare Therapeutics Inc. | 49,000 | 0.00 USD | deriv |
| 31 Mar 2022 | GRANT_AWARD | Pyxis Oncology, Inc. | 66,831 | 0.00 USD | |
| 18 Nov 2021 | PURCHASE | Pyxis Oncology, Inc. | 15,700 | 12.74 USD | |
| 16 Nov 2021 | PURCHASE | Repare Therapeutics Inc. | 7,500 | 28.08 USD | |
| 07 Oct 2021 | GRANT_AWARD | Pyxis Oncology, Inc. | 42,191 | 0.00 USD | deriv |
| 07 Sept 2021 | GRANT_AWARD | Repare Therapeutics Inc. | 42,000 | 0.00 USD | deriv |
| 16 Apr 2021 | OTHER | FIVE PRIME THERAPEUTICS INC | 68,971 | 38.00 USD | |
| 16 Apr 2021 | OTHER | FIVE PRIME THERAPEUTICS INC | 480,000 | — | deriv |
| 09 Apr 2021 | TAX_WITHHOLDING | FIVE PRIME THERAPEUTICS INC | 11,088 | 37.94 USD | |
| 13 Apr 2020 | GRANT_AWARD | FIVE PRIME THERAPEUTICS INC | 75,000 | 0.00 USD | |
| 13 Apr 2020 | GRANT_AWARD | FIVE PRIME THERAPEUTICS INC | 480,000 | 0.00 USD | deriv |
| 31 Jul 2018 | OTHER | Foundation Medicine, Inc. | 33,421 | 137.00 USD | |
| 01 Jan 2018 | GRANT_AWARD | Foundation Medicine, Inc. | 33,421 | 68.20 USD |